Company: EHSI
Filing Date: 2025-09-02
Form Type: PRE 14A
Source: 0001437749-25-028137
Chunk: 5

Company: Elite Health Systems Inc.
Filing Date: 2025-09-02
Form: PRE 14A
Chunk 5
---
 following are some questions that you, as a holder of Elite common stock, may have regarding the Meeting and the proposals presented herein and brief answers to such questions. Elite urges you to carefully read this entire proxy statement and the documents referred to in this proxy statement because the information in this section does not provide all of the information that may be important to you as a stockholder of Elite with respect to such proposals.

Why am I receiving this proxy statement?

You are receiving this proxy statement because you have been identified as a holder of Elite common stock as of the close of business on August 25, 2025 (the “Record Date”), and you are entitled to notice of, and to vote at, the Meeting. This proxy statement contains important information about the Meeting, the various proposals presented and the other business to be considered by Elite stockholders at the Meeting, and you should read it carefully and in its entirety.

What proposals are the stockholders being asked to consider at the Meeting?

At the Meeting, you will be asked to vote regarding the following matters:

1. To elect as directors to the Company’s Board of Directors the five nominees named in the proxy statement to serve for a one-year term expiring at the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified pursuant to the Board Election Proposal;

2. To vote on a proposal to amend the Company’s Certificate of Incorporation to increase the aggregate number of shares of common stock which the Company shall have the authority to issue from 25,000,000 shares to 50,000,000 pursuant to the Authorized Shares Increase Proposal;

3. To vote on a proposal to approve the Company’s 2025 Equity Incentive Plan with 4,500,000 maximum aggregate number of shares of common stock subject to the plan pursuant to the 2025 Equity Incentive Plan Proposal;

4. To vote on a proposal to acquire PSS by issuing 3,158,000 shares of the Company’s common stock in connection with the Acquisition Agreement pursuant to the Acquisition Proposal;

5. To ratify the appointment of Mercurius & Associates LLP as our independent auditors for the fiscal year ending December 31, 2025 pursuant to the Approval of Independent Auditor Proposal;

6. To adjourn the Meeting from time to time to solicit additional proxies in favor of any one or more of the matters identified above for consideration at the Meeting if determined by the chairperson of the Meeting to be necessary or appropriate pursuant to the Approval of Independent Auditor Proposal; and